•
EnChannel Medical, a Guangzhou-based electrophysiology platform company, has reportedly secured RMB 200 million (USD 28 million) in a Series A financing round. The round was co-led by Lapam Capital and Lilly Asia Ventures, with the proceeds earmarked for enhancing clinical filings, commercialization efforts, and research and development systems within the…